Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

NCT06170970 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis
Multiple Sclerosis Fatigue

Interventions

DRUG: Solriamfetol
DRUG: Placebo

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]